ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 86371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 86371; 2) Community: the network communities that were significantly associated with the response to NSC 86371; 3) Molecule: the relationships between components within communities and NSC 86371; 4) MDR: the compounds that were significantly associated with the NSC 86371.

NSC Compound Enrichment Correlation
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0228506033927957 0.27470841
NSC 623436 TGF.alpha.-PE40 0.0228506033927957 -0.46213338
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0228506033927957 0.23549232
NSC 625878 Null 0.0228506033927957 0.38412377
NSC 634785 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride 0.0228506033927957 0.47302763
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.0228506033927957 0.53385147
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0228506033927957 0.32071941
NSC 639187 Landomycin A 0.0228506033927957 0.34976835
NSC 656209 Null 0.0228506033927957 0.28273081
NSC 657270 (+/-) Ethyl trans-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.0228506033927957 0.3038187
Total:139  Current:82    [First] [Prev] [Next] [Last]